Cloning, expression and protective capacity of 37 kDa outer membrane protein gene (ompH) of Pasteurella multocida

H Y Tan1, N H Nagoor, S D Sekaran

  • 1Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Tropical Biomedicine
|March 15, 2011
PubMed

Insights

A novel outer membrane protein H (OmpH) from Pasteurella multocida was identified as a promising vaccine candidate. Recombinant OmpH demonstrated high protection rates in mice and potential for diagnostic kit development.

Area of Science:

  • Veterinary Microbiology
  • Bacterial Pathogenesis
  • Vaccine Development

Background:

  • Pasteurella multocida serotype B:2 is a significant pathogen in livestock.
  • Outer membrane proteins (OMPs) are key targets for vaccine development.
  • Characterization of OmpH from local Malaysian strains is crucial for effective disease control.

Purpose of the Study:

  • To characterize the major outer membrane protein (OmpH) of local Malaysian Pasteurella multocida strains.
  • To evaluate the immunogenic and protective potential of a recombinant OmpH (rOmpH) as a vaccine candidate.
  • To explore the utility of rOmpH in developing a diagnostic kit.

Main Methods:

  • Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting were used to characterize OmpH.
  • The ompH gene was cloned into an Escherichia coli expression vector for recombinant protein production.
  • Mice were immunized with rOmpH and challenged to assess protection.
  • Enzyme-linked immunosorbent assay (ELISA) was explored for diagnostic applications.

Main Results:

  • A 37 kDa OmpH fragment showed high reactivity and was selected as a vaccine candidate.
  • Recombinant OmpH (rOmpH) was successfully produced.
  • Mice immunized intraperitoneally with rOmpH showed 100% protection against Pasteurella multocida challenge.
  • Subcutaneous immunization resulted in 80% protection.
  • The rOmpH showed potential for ELISA-based diagnostics.

Conclusions:

  • The 37 kDa OmpH is a suitable candidate for Pasteurella multocida serotype B:2 vaccine development.
  • Recombinant OmpH offers significant protection and warrants further field studies.
  • rOmpH can be utilized for developing diagnostic tools for Pasteurella multocida infections.